Of note, LINC00961 expression was recently shown to be enhanced in cisplatin-resistant high-grade serous ovarian cancer cells43 and overexpression of LINC00269 impaired migration and invasion capacities in a choriocarcinoma in vitro model44. Here, SPAAR is linked to ovarian serous adenocarcinoma.